R. Gerald Markle (1950-2004)

We offer our respect and condolences to the family and friends of R. Gerald Markle who succumbed to pancreatic cancer on June 23, 2004 after a long, courageous and intelligently waged battle. Jerry was a family man with two lovely daughters, the lively spouse of our director of public policy Ellen Pansky, a wry humorist and a man of singular accomplishment.

R. Gerald “Jerry” Markle, preeminent legal ethics expert and litigator, died at home in South Pasadena on Wednesday, June 23rd, 2004 after a remarkable 27 month survival from diagnosis of pancreatic cancer. Markle advised and represented many of California’s most prominent lawyers and law firms during the past 15 of his 27 years in practice.

1989, Markle and his wife, Ellen A. Pansky, opened a boutique law firm emphasizing the defense of legal malpractice matters and State Bar disciplinary cases. Markle defended several hundreds of attorneys in disciplinary investigations and prosecutions, as well as successfully recovering a number of seven-figure plaintiff’s legal malpractice settlements. He was generally recognized as one of the most effective disciplinary defense counsel in the state.

Markle also served for years as a member and also co-president of the South Pasadena Educational Foundation, and long supported the schools in his community.

Markle received his Bachelor of Arts degree in political science from the University of California at Santa Barbara in 1972. He attended University of Puget Sound School of Law (now Seattle University School of Law), graduating 14th in his class of 219, and receiving his J.D. cum laude in 1976.

He was an avid sports fan, and played many sports including novice ice hockey, golf and softball (even while wearing a portable chemo infusion pump); he owned one of the first pairs of rollerblades ever seen in the San Gabriel Valley, occasionally stopping traffic as he skated on surface streets.

Markle is survived by his wife of 21 years, Ellen, his two daughters Angela and Valerie, his brother John “Larry” Markle of Cave Creek, AZ, and many other close relatives.

Memorial services were held on June 27. In lieu of flowers, donations may be made to (Panceatric Cancer Action Network) or (Cancer Patients Alliance).

For more information on Jerry’s professional life please click here.

Our science board is composed of:

James Abbruzzese, MD Chief, Medical Oncology Duke University

Markus Büchler, MD Chairman, Surgery Heidelberg University, Germany

Ralph Hruban, MD Director, GI / Liver Pathology Johns Hopkins University

Eileen O’Reilly, MD Associate Director for Clinical Research – Memorial Sloan-Kettering Cancer Center

Margaret Tempero, MD Chief, Medical Oncology University of California at San Francisco

Our Philosophy About Pancreatic Cancer

Pancreatic cancer is a serious disease. Taking an aggressive rational stance at the earliest possible time, supported by the best medical team, and treated in the most appropriate manner gives the best chance for survival.

We believe in strong patient-physician bonds, scientifically-based treatment, and that comfort can come from knowing that everything that reasonably can be done – is being done.

That the best approach is meeting cancer of the pancreas head-on and armed with the best available information.

Facebook Fundraising is Easy!

Creating a Facebook Fundraiser is easy: Click the Link below and Facebook will take you through the steps! Dedicate your Birthday or another important date to honor a loved one.


Genetic Testing for Pancreatic Cancer

PROPOSED: Every newly diagnosed person with pancreatic cancer (ductal adenocarcinoma of the pancreas) should receive genetic screening prior to beginning treatment – to test for germline genetic mutations in the homologous recombination DNA repair pathway, including genes such as BRCA1, BRCA2, PALB2, and others. These results, in from 12% to 17% of pancreatic cancer patients, suggest that treatment that includes DNA cross-linking agents such as platinum compounds or PARP inhibitors may be superior to standard best practices therapy.

OFFER: Color Genomics offers a 30-gene cancer panel for $224 (normally $249) when the Promotion Code “PANCREATIC” is entered at checkout (price will reduce upon entering this code). This is a physician-ordered saliva kit. Click Here for more information

RATIONALE: The age of precision medicine in pancreatic cancer is approaching … [MORE]

Our mission is to promote awareness, increase education, and further pancreatic cancer research, specifically research aimed at early diagnosis.

Pancreatic cancer is the 3rd leading cause of cancer-related death in the U.S. It is expected to become the 2nd leading cause of cancer-related death by the year 2020. Studies show that death rates for pancreatic cancer are increasing while for most other cancers they are declining.
It’s time to change these statistics!

Early diagnosis is key:
Survival increases dramatically if patients are diagnosed in time for surgery!

For medical information Click Here for our sister site


Walk, Run, or Choose your own!

Choose a walk, run, or any other activity that you like and work to raise donations leading up to your Event! Simply set up your participation page and we will be in touch!


Already registered for your next Race? Dedicate your participation to Pancreatic Cancer. Simply set up your participation page and together we will work towards our shared mission!


Creating a Facebook Fundraiser is easy: Click the Link below and Facebook will take you through the steps! Dedicate your Birthday or another important date to honor a loved one.

Participate in #GivingTuesday for Pancreatic Cancer on December 3rd 2019!! 

Click Here to Add a Calendar Reminder! 

Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to help fight pancreatic cancer!
AmazonSmile is the same Amazon you know. Same products, same prices, same service. Simply use our Link to start shopping!

Speak with a Survivor:

Call 1-800-433-0464 for a free service that will place you in contact with a fellow survivor, or to volunteer to contact someone more recently diagnosed.

Pancreatic Cancer Blog

One of the observations that physicians often made when the standard of care treatment typically consisted of the chemotherapy drug agent of gemcitabine alone, was that many patients with pancreatic cancer (ductal adenocarcinoma of the pancreas) seemed to feel better after the initiation of treatment… More Here



You can honor your loved one by sharing your story with us. Whether it’s your personal story, honoring a friend or relative’s journey, or why you support the cause, we want to hear from you!

Best of the Blog

Join us on Social Media !



Pancreatic cancer is expected to become the 2nd leading cause of cancer-related death by the year 2020